Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Recent Articles in CRO/CMO Services

Shanghai ZhenGe Completes $100 Million Round for Biologic CDMO Services
Innoforce Raises $157 Million for Cell Therapy, Gene Therapy and RNA CDMO
Frontage Acquires Majority Stake in Wuhan Heyan Biomedical, a CRO
dMed-Clinipace Raises $50 Million for China-US Clinical CRO Operations
Viva Bio and BioMap Form AI Biologic Drug Discovery Collaboration
ChinaBio Event
Singapore and Digital
April 26-27, 2023
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China